(0.70%) 5 117.75 points
(0.11%) 38 329 points
(0.98%) 17 739 points
(0.66%) $84.12
(-3.79%) $1.576
(0.77%) $2 360.60
(1.05%) $27.64
(0.50%) $925.10
(0.03%) $0.932
(0.46%) $11.00
(0.00%) $0.799
(-0.31%) $91.88
Live Chart Being Loaded With Signals
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 122 000 |
Average Volume | 102 983 |
Market Cap | 667.35M |
EPS | HKD0 ( 2023-08-29 ) |
Last Dividend | HKD0.00420 ( 2022-06-07 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -18.00 |
ATR14 | HKD0 (0.00%) |
Fusen Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Fusen Pharmaceutical Financials
Annual | 2023 |
Revenue: | HKD565.61M |
Gross Profit: | HKD299.51M (52.95 %) |
EPS: | HKD-0.0500 |
FY | 2023 |
Revenue: | HKD565.61M |
Gross Profit: | HKD299.51M (52.95 %) |
EPS: | HKD-0.0500 |
FY | 2022 |
Revenue: | HKD491.76M |
Gross Profit: | HKD225.02M (45.76 %) |
EPS: | HKD-0.0458 |
FY | 2021 |
Revenue: | HKD385.66M |
Gross Profit: | HKD211.13M (54.75 %) |
EPS: | HKD0.0210 |
Financial Reports:
No articles found.
Fusen Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.00620 | 2018-09-13 |
Last Dividend | HKD0.00420 | 2022-06-07 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | HKD0.0436 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.15 | -- |
Div. Sustainability Score | 1.583 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.237 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3958.HK | Ex Dividend Knight | 2023-05-23 | Annually | 0 | 0.00% | |
1786.HK | Ex Dividend Junior | 2023-07-04 | Sporadic | 0 | 0.00% | |
0822.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
2362.HK | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% | |
1349.HK | Ex Dividend Junior | 2023-06-05 | Annually | 0 | 0.00% | |
0393.HK | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
6668.HK | Ex Dividend Junior | 2023-06-13 | Annually | 0 | 0.00% | |
1899.HK | Ex Dividend Junior | 2023-06-13 | Annually | 0 | 0.00% | |
0927.HK | Ex Dividend Knight | 2023-08-29 | Semi-Annually | 0 | 0.00% | |
0057.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0641 | 1.500 | -1.283 | -1.924 | [0 - 0.5] |
returnOnAssetsTTM | -0.0270 | 1.200 | -0.900 | -1.080 | [0 - 0.3] |
returnOnEquityTTM | -0.0612 | 1.500 | -1.791 | -2.69 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.853 | 0.800 | -0.735 | -0.588 | [1 - 3] |
quickRatioTTM | 0.329 | 0.800 | -2.77 | -2.22 | [0.8 - 2.5] |
cashRatioTTM | 0.0524 | 1.500 | -0.820 | -1.230 | [0.2 - 2] |
debtRatioTTM | 0.255 | -1.500 | 5.75 | -8.62 | [0 - 0.6] |
interestCoverageTTM | 6.34 | 1.000 | 8.76 | 8.76 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0619 | 2.00 | -0.0206 | -0.0412 | [0 - 30] |
freeCashFlowPerShareTTM | -0.118 | 2.00 | -0.0590 | -0.118 | [0 - 20] |
debtEquityRatioTTM | 0.609 | -1.500 | 7.57 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.530 | 1.000 | 4.51 | 4.51 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0379 | 1.000 | -1.241 | -1.241 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.135 | 1.000 | -1.862 | -1.862 | [0.2 - 2] |
assetTurnoverTTM | 0.421 | 0.800 | -0.527 | -0.422 | [0.5 - 2] |
Total Score | 1.583 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -16.62 | 1.000 | -1.780 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0612 | 2.50 | -1.151 | -2.69 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.118 | 2.00 | -0.0393 | -0.118 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0619 | 2.00 | -0.0206 | -0.0412 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.324 | 1.500 | -1.174 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0819 | 1.000 | -4.55 | 0 | [0.1 - 0.5] |
Total Score | -1.109 |
Fusen Pharmaceutical
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators